An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)
Clinical trial NCT06073132 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06073132
- Sponsor
- TWi Biotechnology, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-04
- Primary completion
- 2026-06-10
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.